Retrospective Chart Review of Duloxetine and Pregabalin in the Treatment of Painful Neuropathy

REFERENCES

• Amato, A. A., Barohn, R. J., Sahenk, Z., Tutschka, P. J., & Mendell, J. R. (1993). Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology, 43(8), 1513–1518.
   Google Scholar
• Arezzo, J. C., Rosenstock, J., Lamoreaux, L., & Pauer, L. (2008). Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol, 8, 33.
   PubMed Web of Science ®Google Scholar
• Barohn, R. J. (1998). Approach to peripheral neuropathy and neuronopathy. Semin Neurol, 18(1), 7–18.
   Google Scholar
• Bolton, C. F., Gilbert, J. J., Hahn, A. F., & Sibbald, W. J. (1984). Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry, 47(11), 1223–1231.
   PubMed Web of Science ®Google Scholar
• Bymaster, F. P., Dreshfield-Ahmad, L. J., Threlkeld, P. G., Shaw, J. L., Thompson, L., Nelson, D. L., (2001). Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology, 25(6), 871–880.
   PubMed Web of Science ®Google Scholar
• Dooley, D. J., Donovan, C. M., & Pugsley, T. A. (2000). Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther, 295(3), 1086–1093.
   PubMed Web of Science ®Google Scholar
• Dworkin, R. H., Corbin, A. E., Young, J. P., Jr., Sharma, U., LaMoreaux, L., Bockbrader, H., (2003). Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology, 60(8), 1274–1283.
   PubMed Web of Science ®Google Scholar
• Feinglass, E. J., Arnett, F. C., Dorsch, C. A., Zizic, T. M., & Stevens, M. B. (1976). Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore), 55(4), 323–339.
   PubMed Web of Science ®Google Scholar
• Fink, K., Dooley, D. J., Meder, W. P., Suman-Chauhan, N., Duffy, S., Clusmann, H., (2002). Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology, 42(2), 229–236.
   PubMed Web of Science ®Google Scholar
• Frampton, J. E., & Scott, L. J. (2004). Pregabalin: in the treatment of painful diabetic peripheral neuropathy. Drugs, 64(24), 2813–2820; discussion 2821.
   Google Scholar
• Freynhagen, R., Strojek, K., Griesing, T., Whalen, E., & Balkenohl, M. (2005). Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain, 115(3), 254–263.
   PubMed Web of Science ®Google Scholar
• Goldstein, D. J., Lu, Y., Detke, M. J., Lee, T. C., & Iyengar, S. (2005). Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain, 116(1–2), 109–118.
   PubMed Web of Science ®Google Scholar
• Guy, W. (1976). Clinical Global Impression (CGI). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD, U.S. Department of Health, Education, and Welfare (1976), 217–222.
   Google Scholar
• Hadjivassiliou, M., Grunewald, R. A., Kandler, R. H., Chattopadhyay, A. K., Jarratt, J. A., Sanders, D. S., (2006). Neuropathy associated with gluten sensitivity. J Neurol Neurosurg Psychiatry, 77(11), 1262–1266.
   PubMed Web of Science ®Google Scholar
• Katz, J. S., Saperstein, D. S., Gronseth, G., Amato, A. A., & Barohn, R. J. (2000). Distal acquired demyelinating symmetric neuropathy. Neurology, 54(3), 615–620.
   PubMed Web of Science ®Google Scholar
• Kelly, J. J., Jr. (1985). Peripheral neuropathies associated with monoclonal proteins: a clinical review. Muscle Nerve, 8(2), 138–150.
   Google Scholar
• Kelly, J. J., Jr., Kyle, R. A., Miles, J. M., O'Brien, P. C., & Dyck, P. J. (1981). The spectrum of peripheral neuropathy in myeloma. Neurology, 31(1), 24–31.
   PubMed Web of Science ®Google Scholar
• Kelly, J. J., Jr., Kyle, R. A., O'Brien, P. C., & Dyck, P. J. (1979). The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol, 6(1), 1–7.
   PubMed Web of Science ®Google Scholar
• Lesser, H., Sharma, U., LaMoreaux, L., & Poole, R. M. (2004). Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology, 63(11), 2104–2110.
   PubMed Web of Science ®Google Scholar
• Mellgren, S. I., Conn, D. L., Stevens, J. C., & Dyck, P. J. (1989). Peripheral neuropathy in primary Sjogren's syndrome. Neurology, 39(3), 390–394.
   PubMed Web of Science ®Google Scholar
• Raskin, J., Pritchett, Y. L., Wang, F., D'Souza, D. N., Waninger, A. L., Iyengar, S., (2005). A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med, 6(5), 346–356.
   PubMed Web of Science ®Google Scholar
• Rosenstock, J., Tuchman, M., LaMoreaux, L., & Sharma, U. (2004). Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain, 110(3), 628–638.
   PubMed Web of Science ®Google Scholar
• Sabatowski, R., Galvez, R., Cherry, D. A., Jacquot, F., Vincent, E., Maisonobe, P., (2004). Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain, 109(1–2), 26–35.
   PubMed Web of Science ®Google Scholar
• Saperstein, D. S., Katz, J. S., Amato, A. A., & Barohn, R. J. (2001). Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve, 24(3), 311–324.
   PubMed Web of Science ®Google Scholar
• Schroder, J. M. (1993). Neuropathy associated with mitochondrial disorders. Brain Pathol, 3(2), 177–190.
   Google Scholar
• Taylor C. P. (2004). The biology and pharmacology of calcium channel alpha2-delta proteins Pfizer Satellite Symposium to the 2003 Society for Neuroscience Meeting. Sheraton New Orleans Hotel, New Orleans, LA November 10, 2003. CNS Drug Reviews, 10, 183–188.
   Google Scholar
• Tolle, T., Freynhagen, R., Versavel, M., Trostmann, U., & Young, J. P., Jr. (2008). Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain, 12(2), 203–213.
   PubMed Web of Science ®Google Scholar
• Wernicke, J. F., Pritchett, Y. L., D'Souza, D. N., Waninger, A., Tran, P., Iyengar, S., (2006). A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology, 67(8), 1411–1420.
   PubMed Web of Science ®Google Scholar
• Wernicke, J. F., Wang, F., Pritchett, Y. L., Smith, T. R., Raskin, J., D'Souza, D. N., (2007). An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain. Pain Med, 8(6), 503–513.
   Google Scholar
• Wolfe, G. I., & Barohn, R. J. (1998). Cryptogenic sensory and sensorimotor polyneuropathies. Semin Neurol, 18(1), 105–111.
   Google Scholar